Sepio Capital, LP Abb Vie Inc. Transaction History

Sepio Capital, LP

$1.03 Billion
Q4 2024

A detailed history of Sepio Capital, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Sepio Capital, LP holds 167,373 shares of ABBV stock, worth $33.8 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares

167,373

Previous 205,459 18.54%

Holding current value

$33.8 Million

Previous $40.6 Million 26.7%

% of portfolio

2.88%

Previous 3.92%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$164.99 - $203.87 $6.28 Million - $7.76 Million	-38,086 Reduced 18.54%	167,373 $29.7 Million
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $11.8 Million - $14.4 Million	72,207 Added 54.19%	205,459 $40.6 Million
Q2 2024 Aug 15, 2024	SELL	$154.79 - $180.76 $4.33 Million - $5.06 Million	-27,995 Reduced 17.36%	133,252 $22.9 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $246,762 - $281,162	-1,544 Reduced 0.95%	161,247 $29.4 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $2.38 Million - $2.69 Million	-17,328 Reduced 9.62%	162,791 $25.2 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $3.08 Million - $3.56 Million	-23,033 Reduced 11.34%	180,119 $26.8 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $5.66 Million - $7.04 Million	42,715 Added 26.62%	203,152 $27.4 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $5.46 Million - $6.28 Million	-37,732 Reduced 19.04%	160,437 $25.6 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $4.36 Million - $5.23 Million	-31,522 Reduced 13.72%	198,169 $32 Million
Q3 2022 Oct 28, 2022	BUY	$134.21 - $153.93 $17.2 Million - $19.8 Million	128,412 Added 126.79%	229,691 $30.8 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $10.7 Million - $13.6 Million	77,950 Added 334.13%	101,279 $15.5 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $514,062 - $637,806	-3,895 Reduced 14.31%	23,329 $3.78 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $2.92 Million - $3.7 Million	27,224 New	27,224 $3.69 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $106 Million - $124 Million	-1,371,271 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $107 Million - $132 Million	1,371,271 New	1,371,271 $126 Million

Others Institutions Holding ABBV

# of Institutions

4,095

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.

Account